Adaptimmune Therapeutics plc - American Depositary Shares (NQ:ADAP)

0.1601 -0.0199 (-11.06%)
Streaming Delayed Price Updated: 3:31 PM EDT, Oct 14, 2025 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 42,342,314
Open 0.1600
Bid (Size) 0.1600 (196)
Ask (Size) 0.1601 (38)
Prev. Close 0.1800
Today's Range 0.1471 - 0.1650
52wk Range 0.0403 - 0.8996
Shares Outstanding 1,535,653,620
Dividend Yield N/A

Performance

YTD
-74.3%
-74.3%
1 Month
+140.4%
+140.4%
3 Month
-43.0%
-43.0%
6 Month
-31.6%
-31.6%
1 Year
-81.8%
-81.8%

More News

Read More

Frequently Asked Questions

Is Adaptimmune Therapeutics plc - American Depositary Shares publicly traded?
Yes, Adaptimmune Therapeutics plc - American Depositary Shares is publicly traded.
What exchange does Adaptimmune Therapeutics plc - American Depositary Shares trade on?
Adaptimmune Therapeutics plc - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Adaptimmune Therapeutics plc - American Depositary Shares?
The ticker symbol for Adaptimmune Therapeutics plc - American Depositary Shares is ADAP on the Nasdaq Stock Market
What is the current price of Adaptimmune Therapeutics plc - American Depositary Shares?
The current price of Adaptimmune Therapeutics plc - American Depositary Shares is 0.1601
When was Adaptimmune Therapeutics plc - American Depositary Shares last traded?
The last trade of Adaptimmune Therapeutics plc - American Depositary Shares was at 10/14/25 03:31 PM ET
What is the market capitalization of Adaptimmune Therapeutics plc - American Depositary Shares?
The market capitalization of Adaptimmune Therapeutics plc - American Depositary Shares is 245.86M
How many shares of Adaptimmune Therapeutics plc - American Depositary Shares are outstanding?
Adaptimmune Therapeutics plc - American Depositary Shares has 246M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.